Provided by Tiger Fintech (Singapore) Pte. Ltd.

PainReform

2.79
+0.14005.28%
Post-market: 2.830.0401+1.44%17:40 EDT
Volume:73.41K
Turnover:205.20K
Market Cap:2.44M
PE:-0.02
High:2.95
Open:2.72
Low:2.68
Close:2.65
Loading ...

Company Profile

Company Name:
PainReform
Exchange:
NASDAQ
Establishment Date:
2007
Employees:
7
Office Location:
65 Yigal Alon St.,Tel Aviv,Israel
Zip Code:
6744316
Fax:
- -
Introduction:
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. It is currently conducting Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. The company was incorporated in 2007 and is based in Tel Aviv, Israel.

Directors

Name
Position
Ehud Geller
Acting Chief Financial Officer and Executive Chairman
Eli Hazum
Acting Chief Executive Officer and Chief Technology Officer and Director
Augustine Lawlor
External Director
Ellen S. Baron
External Director
Assif Stoffman
Director
Efi Cohen Arazi
Director

Shareholders

Name
Position
Eli Hazum
Acting Chief Executive Officer and Chief Technology Officer and Director
Sigal Aviel
Chief Operating Officer
Ehud Geller
Acting Chief Financial Officer and Executive Chairman
David E. Weinstein
President and Chief Medical Officer